Dual antiplatelet therapy after coronary artery bypass grafting: A safe option after all? Comment on a published meta‐analysis
- 24 March 2020
- journal article
- letter
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 35 (5), 1159-1160
- https://doi.org/10.1111/jocs.14507
Abstract
Click on the book chapter title to read more.Keywords
Funding Information
- Universidade do Porto/FMUP, FSE-Fundo Social Europeu, NORTE 2020-Programa Operacional Regional do Norte (NORTE-08-5369-FSE-000024-Programas Doutorais)
This publication has 6 references indexed in Scilit:
- The 2017 EACTS guidelines on perioperative medication in adult cardiac surgery and patient blood managementEuropean Journal of Cardio-Thoracic Surgery, 2017
- 2017 EACTS Guidelines on perioperative medication in adult cardiac surgeryEuropean Journal of Cardio-Thoracic Surgery, 2017
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery DiseaseJournal of the American College of Cardiology, 2016
- Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-AnalysisJournal of Cardiac Surgery, 2013
- Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting studyAmerican Heart Journal, 2010
- Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2009